Navigation Links
PAL-MED CONNECT partners with Briefings in Palliative, Hospice, and Pain Medicine & Management
Date:10/4/2010

New Rochelle, NY, October 4, 2010 Briefings in Palliative, Hospice, and Pain Medicine & Management, the e-newsletter companion to Journal of Palliative Medicine published by Mary Ann Liebert, Inc. (www.liebertpub.com), is pleased to announce a collaboration with The Institute for Palliative Medicine's (www.palliativemed.org) PAL-MED CONNECT (http://palmedconnect.org/) hotline to create a new monthly feature for the e-newsletter. Each month, Briefings will now include a valuable case study focusing on patients with advanced pain and symptom management challenges, or chronic or life-threatening illness.

Briefings will present practical, clinical case studies encountered by callers to PAL-MED CONNECT. Anticipated subjects include pain management, safety and efficacy of opioids, opioid conversion, neuropathic pain symptoms, difficult family conversations, decision-making about NG tubes, and other key topics. The studies will initially appear on the last Wednesday of each month with the potential for them to appear more frequently based on reader response. The first case study (http://www.liebertpub.com/palliative/archive/2010/Sept_10/Sept_29_10.htm) was published on September 29, 2010.

The PAL-MED CONNECT hotline is a grant-funded hotline that provides free access for healthcare professionals seeking expertise and educational resources related to palliative care and complex symptom management. The hotline can be accessed by physicians, physician assistants, nurse practioners, pharmacists, nurses, and other healthcare professionals. Callers speak directly clinician to expert clinician, at no charge. The hotline is available at 1-877-PAL-MED4.

"This California based hotline is gaining attention from healthcare professiona
'/>"/>

Contact: Vicki Cohn
vcohn@liebertpub.com
914-740-2156
Mary Ann Liebert, Inc./Genetic Engineering News
Source:Eurekalert  

Page: 1 2

Related biology news :

1. Connection between light at night and cancer revealed in additional study
2. Connection between light at night (LAN) and cancer revealed in additional study
3. Cactus genes connect modern Mexico to its prehistoric past
4. Researchers connect APC protein to autism and mental retardation
5. Brain connections break down as we age
6. Greenhouse gas calculator connects farming practices with carbon credits
7. Calcium connections: Basic pathway for maintaining cells fuel stores
8. Searching for causes of neural disconnection in schizophrenia
9. Connecting the dots: How light receptors get their message across
10. Connection elucidated between obesity, salt sensitivity and high blood pressure
11. Biomatrica Launches New Partnership Program - Biomatrica Connect(TM)
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
PAL-MED CONNECT partners with Briefings in Palliative, Hospice, and Pain Medicine & Management
(Date:12/17/2014)... , Dec. 15, 2014 The Defense ... it easier to detect and prevent counterfeit microcircuits ... Today the agency started performing an in-house microcircuit ... validate the authenticity of purchased microcircuits while increasing ... quality control measures will be conducted at DLA,s ...
(Date:12/15/2014)... 2014 Research and Markets ( ... "Global Facial Recognition Market 2015-2019" report ... http://photos.prnewswire.com/prnh/20130307/600769 Facial recognition is a ... recognition system measures the overall facial feature of ... and the distance between eyes. Facial recognition is ...
(Date:12/10/2014)... 8, 2014 You,ve been here before: you desperately ... remember your password, site key or the answer to your ... grade teacher? Today, Hoyos Labs , ... that will finally put an end to the frustration that ... . 1U leverages a user,s smartphone to acquire his ...
Breaking Biology News(10 mins):Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 2Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 3Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 3The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 2The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 3
... Society of Interventional Radiology (SIR) will present the ... prostate and bone cancer; herniated disks; peripheral arterial ... more at its 34th Annual Scientific Meeting March ... San Diego, Calif. Highlights of embargoed ...
... 2009) One of the nation,s oldest and ... than $68,000 in travel fellowships to underrepresented minority ... conference in New Orleans, April 18-22. The American ... announced that 40 fellows will receive the travel ...
... (February 25, 2009) A major asthma discovery by a ... Immunology has been licensed by MedImmune, a leading innovation-focused ... MedImmune licensed the discovery to explore its use ... treating asthma. Under the agreement, ...
Cached Biology News:Society of Interventional Radiology hosts 34th annual scientific meeting 2Society of Interventional Radiology hosts 34th annual scientific meeting 3Society of Interventional Radiology hosts 34th annual scientific meeting 440 minority scientists receive travel fellowships to Experimental Biology 2009 in New Orleans 240 minority scientists receive travel fellowships to Experimental Biology 2009 in New Orleans 3La Jolla Institute signs exclusive license agreement with Medimmune on major asthma discovery 2La Jolla Institute signs exclusive license agreement with Medimmune on major asthma discovery 3
(Date:12/24/2014)... Texas , Dec. 23, 2014 ... company focused on gynecologic disease, announced today that ... Schuler , Birchview Fund LLC and several Vermillion ... of unregistered shares of Vermillion,s common stock and ... stock in a private placement.  ...
(Date:12/24/2014)... Fla. , Dec. 23, 2014  Rock Creek ... that it has filed a Clinical Trial Application (CTA) ... Healthcare products Regulatory Agency (MHRA) seeking regulatory approval to ... lead molecule, Anatabine Citrate. Contingent on the ... conduct a Phase I trial to assess the safety, ...
(Date:12/22/2014)... 22, 2014   Synthetic Biologics, Inc. ... pathogen-specific therapies for serious infections and diseases, ... today announced positive topline safety and tolerability ... of SYN-004, the Company,s investigational oral beta-lactamase ... difficile (C. difficile) infection, antibiotic-associated diarrhea ...
(Date:12/22/2014)... , Dec. 22, 2014 GenomeDx Biosciences today ... Prostate Cancer Classifier, a genomic test for prostate cancer, ... high-risk men managed by radical prostatectomy without adjuvant therapy. ... is relatively uncommon, using tumor genomics to identify these ... disease is an important advance. The study has been ...
Breaking Biology Technology:Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 2Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 3Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 4Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 5Rock Creek Pharmaceuticals Files Clinical Trial Application in the UK for Clinical Trials of Anatabine Citrate Formulations 2Rock Creek Pharmaceuticals Files Clinical Trial Application in the UK for Clinical Trials of Anatabine Citrate Formulations 3Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 2Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 3Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 4Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 5Study Published in European Urology Shows that the Decipher Prostate Cancer Classifier is Predictive of Rapid Metastasis in High-Risk Men who have had Prostate Surgery 2Study Published in European Urology Shows that the Decipher Prostate Cancer Classifier is Predictive of Rapid Metastasis in High-Risk Men who have had Prostate Surgery 3
... Corporation (NASDAQ: TECH ) announced that its Board ... per share for the quarter ended March 31, 2011.  The ... common shareholders of record on May 13, 2011.  Future cash ... a quarterly basis. Techne Corporation has two operating ...
... (Nasdaq: DNDN ) today reported results for the first ... 31, 2011 was $28.1 million compared to $21,000 for the quarter ... for the quarter ended March 31, 2011 was $111.8 million, or ... for the quarter ended March 31, 2010 (which included a non-cash ...
... Today Divine Skin Inc. (OTC Bulletin Board: ... DS Laboratories line for hair and skin. The company signed ... United States. It estimates an average of $300 per month ... well-developed online, luxury, pharmaceutical, and specialty channels, Divine Skin,s distribution ...
Cached Biology Technology:Dendreon Reports First Quarter 2011 Financial Results 2Dendreon Reports First Quarter 2011 Financial Results 3Dendreon Reports First Quarter 2011 Financial Results 4Dendreon Reports First Quarter 2011 Financial Results 5Divine Skin Announces Four Deals for Explosive Distribution Growth 2Divine Skin Announces Four Deals for Explosive Distribution Growth 3
... CyScribe GFX Purification Kit, 50 ... labeled cDNA probesProvides efficient removal of ... labeling reactions with superior yields of ... the purification of cDNA labeled by ...
Detects activated caspases in living cells. Simple/sensitive/straight-forward procedure takes only 30 minutes. Results can be analyzed by flow cytometry/fluorescence microscopy/fluorescence plate rea...
Apoptosis Detection Systems and Reagents...
Bovine Serum Available Anticoagulants: N-02: Citrate N-04: Heparin (Na) N-06: K2EDTA N-08: Potassium Oxalate N-10: EDTA (Na) N-03: Alsevers N-05: ACD N-07: CPD N-09: K3EDTA N-11:...
Biology Products: